Cerus CERS
NASDAQ CERS
$2.51 -0.03 (-1.18%)
As of: Sep 9, 2026 · 3:59 PM EDT

Cerus (CERS) Selling, General & Administrative (2010 - 2026)

Analysis

Cerus (CERS) Selling, General & Administrative (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 4.03 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 617.90 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 3.20 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 2.23 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 1.80 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 561.20 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -964.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 358.70 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 369.70 Mn
10 Cerus 504.42 Mn 448.16 Mn 29.53 Mn 22.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.86 Mn
Mar 31, 2026 19.95 Mn
Jun 30, 2025 21.18 Mn
Mar 31, 2025 20.29 Mn
Sep 30, 2022 19.91 Mn
Jun 30, 2022 19.53 Mn
Mar 31, 2022 20.74 Mn
Dec 31, 2021 22.00 Mn
Sep 30, 2021 20.36 Mn
Jun 30, 2021 19.76 Mn
Mar 31, 2021 19.17 Mn
Dec 31, 2020 18.69 Mn
Sep 30, 2020 16.30 Mn
Jun 30, 2020 16.11 Mn
Mar 31, 2020 15.91 Mn
Dec 31, 2019 17.16 Mn
Sep 30, 2019 16.14 Mn
Jun 30, 2019 16.74 Mn
Mar 31, 2019 16.16 Mn
Dec 31, 2018 14.83 Mn